Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PDA-2 > Eicosanoids > Flashcards

Eicosanoids Flashcards

1
Q

eicosanoids def

A

describes the families of prostaglandins, leukotrienes

mostly derived from arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

biosynthesis of eicosanoids

release of arachidonic acid

A

release of arachidonic acid (free arachidonic acid is very low, but is usually found esterified to membrane phospholipids. Phospholipase A2 is a Ca-dependent enzyme that hydrolyzes the sn2 ester bond of phospholipid and releases arachidonic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

biosynthesis of eicosanoids

cyclooxygenase

A

2 isoforms COX1 and COX2
each isoforms has 2 distinct activities
1. oxygenates and cyclizes the precursor fatty acid to form cyclic endoperoxide, PGG2
2. peroxidase activity that converts PGG2 to PGH2
3. COX 1: heme protein, membrane bound, small active site, different chromosome, constitutive. COX 2: heme protein, membrane bound, large active site, inducible

Fate of PGH2: transformed enzymatically into products (PGI2, TXA2, PGE2, PGF2a) PGE2 : PGE1 :: 2 db : 1 db

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

biosynthesis of eicosanoids

Lipoxygenase

A

family of cytosolic enzymes that catalyze the oxygenation of fatty acids to corresponding lipid hydroperoxides

lipoxygenases differ in specificity depending on where they attach the hydroperoxy group and tissues differ in the lipoxygenases that they have

most important lipoxygenase is 5-lipoxygenase bc it leads to the formation of leukotrienes

activation of 5-lipoxygenase requires Ca and 5-lipoxygenase activating protein (FLAP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

biosynthesis of eicosanoids

cyp p450

A

metabolize arachidonic acid to EETs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

inhibitors of eicosanoid biosynthesis

via phospholipase A2

A

activated by Ca, inhibited by drugs that reduce the availability of Ca

glucocorticoids induce synthesis of annexins that inhibit phospholipase A2 activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

inhibitors of eicosanoid biosynthesis

via cyclooxygenase

A

aspirin and NSAIDS inhibit COX1 and COX2

glucocorticoids decrease expression of COX 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inhibitors of eicosanoid biosynthesis

via lipoxygenase

A

inhibitors of 5-lipoxygenase- zileuton (oral admin, t.5=2.5 hrs, metabolized by CYP enzymes, inhibits cys-LTs for bronchoconsttriction and increases vascular permeability and LTB4 for chemotaxis not many SE, its a prophylactic treatment of mild asthma)

Cysteinyl leukotriene receptor antagonist- zafirlukast (oral admin, t.5=10 hrs, metabolized by CYP2C9/3A4 inhibits Cys-LTs, treats mild asthma)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Eicosanoid catabolism

A

infuse PGE1 - 99% inactivated during one passage thru the pulmonary circulation

2 steps:
1. oxidation by PG dehydrogenase, follwed by reduction by PG reductase fast

  1. B and omega oxidation–>polar compound–>excreted Slow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cellular mechanism of eicosanoids

A

prostaglandins: wide effects by a variety of GPCRs
leukotrienes: receptors identified for LTB4, cyseinyl leukotrienes LTC4 and LTD4 coupled to GPCR activation increases intracellular CA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pain and eicosanoids

A

in the periphery, PGE2 and PGI1 lower the threshold of nociceptors. hyperalgesia. PGs potentiate pain producing activity of brady kinin and autocoids

in the CNS: COX2 is expressed in the dorsal horn of the sp cd and espression increases during inflammation, central PGE2 activates spinal neurons and microglia that can contribute to neuropathic pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

fever and eicosanoids

A

fever results from the production of PG, primarily PGE2 from vascular endothelial cells via COX2. These PGs generate the neuronal signals that activate the thermoregulatory center in anterior hypothalamus. PGE2 synthesis is stimulated by endogenous (IL1) or exogenous (lipopolysaccharide) pyrogens

PGF2a and PGI2 induce feve but do not contribute to the pyretic response. TXA2 does not induce fever.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

platelets and eicosanoids

A

activation of platelet membrane PLA2 causes release of arachidonic acid and its transformation into TXA2 by COX1

TXA2: promotes platelet aggregation by stimulating the TP receptor. TP receptor is coupled to increase in intracellular Ca

PGI2: inhibits platelet aggregation via stimulation of IP receptor that couples to cAMP. cell source of PGI2 is endothelial cells (PLA)–> release of arachidonic acid and metabolism by COX1 and/or COX2 (inflammation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Repro and eicosanoids

A

uterus/pregnancy: associated increase in COX1 and COX2

PGI2: contributes to quiescent state of uterine activity during early pregnany, relaxation of uterine tone via increase of cAMP

PGE2: initiation and progression of labor by inducing uterine contractility, cervical ripening,

PGF2a: mediates uterine contractility during labor, conc increase in menstrual fluid and cause vasoconstriction, uterine contraction, pain

1’ dysmenorrhea: menstrual pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CV smooth muscle and eicosanoids

A

prostaglandins: systemic BP falls in response to PGE2, and hypotension after IV PGI2

PGE2: and PGI2: predominantly vasodilators
TXA2: potent vasoconstrictor
PGF2a: vasocontriction

locally produced PGs counteract the effects of circulating vasoconstrictor autocoids. TO MAINTAIN blood flow to vital organs

PGs maintain patency of ductus arteriosus during fatal life. allows right blood to bypass the pulm system

PGE2: major PG that affects tone of ductus, relaxation via EP4 receptor, COX 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

bronchial tracheal smooth muscle and eicosanoids

A

when lung get antigen, autocoids are produced (prostaglandins and leukotrienes)

PGEs, PGI2 relax
PGF2a, TXA2 all constrict
LTC4, LTD4 constrict

bronconstriction to leukotrienes predominates

17
Q

Kidney and eicosanoid

A

PGs modulate renal blood flow

COX1 and 2

PGE2 and PGI2 increase RBF bc of vasodilation promote diuresis and natriuresis

18
Q

GI and eicosanoids

A

COX-1: production of cytoprotective PGs

PGE2 and PGI2: inhibit gastric acid secretion, increase gastric mucosal blood flow

PGE2: stimulates release of viscous mucos, bicarb secretion, contracts GI smooth muscle

19
Q

inflammatory and immune response eicosanoids

A

COX2 mediated: PGs and leukotrienes released by a number of mechanical/thermal chemical and bacterial insults

PGs: signs and symptoms of inflammation

LTC4 and LTD4: increase vascular permeability
LTB4: chemoattractant for neutrophils

20
Q

Cancer and eicosanoids

A

in certain malignancies increased concentration of PGs, which induce cell proliferation

COX-2 induced in certain cancers

21
Q

therapeutic uses of prostaglandins

A

limited bc significant adverse side effects and short half lives in circulation

22
Q 
dinoprostone
therapeutic use, preparation, MOA
Therapeutic use:
Preparation:
MOA: 
Side effects:
Therapeutic use:
Preparation:
MOA: 
Side effects:
A

analog of PGE2
Therapeutic use: cervical ripening in pregnancy

Preparation: cervical gel 240 mg
MOA: promotes cervical ripening (via activation of collagenase) & relaxes cervix increases cAMP

Therapeutic use: termination of preg
Preparation:vaginal suppository
MOA: uterine contractions via EP1/3 receptors increase Ca

Side effects: GI releated fever uterine rupture, CX in F w/Hx of C-section/uterine SgX

23
Q 
Carboprost
Therapeutic use:
Preparation:
MOA: 
Side effects:
Therapeutic use:
Preparation:
MOA: 
Side effects:
A

PGF2a analog (analog is t.5=8 min reg PGF2a=15 s)
Therapeutic use: 2nd trimester abortion (13 to 20 wks)
Preparation: im shot 250 mg
MOA: stimulates uterine contractions by FP receptors

Therapeutic use:controls post partum hemorrhage
Preparation: im 250
MOA: myometrial contractions via fP R hemostasis at placenta site
Side effects: GI, fever, uterine rupture Cx in women w/Hx of C-sec/Uterine SgX, sometimes bronchoconstrictions

24
Q 
misoprostal 
Therapeutic use:
Preparation:
MOA: 
Side effects:
A

(PGE1 analog)
Therapeutic use: replacement therapy for ulcers dutu NSAIDs
Preparation: oral admin 4x/day
MOA: supresses gasstric acid secretion by stimulating EP3 receptors on parietal cells, dec cAMP increases mucin and bicarb and mucosals blood flow
Side effects: diarrhea and CX in pregnancy

use misoprostal and methotrexate to early abortion

25
Q 
Alprostadil
Therapeutic use:
Preparation:
MOA: 
Side effects:
A

PGE1 analog
Therapeutic use: impotence
Preparation: intracavernous injection/ intraurethral injection
MOA: EP2/EP4 increase in cAMP which relaxes smooth muscle of corpus cavernosum
Side effects: pain at site of injection, priapism (prolonged erection)
Therapeutic use: maintenance of patent ductus arteriosus
Preparation:IV
MOA: EP2/EP4 cAMP-mediated relaxtion of ductus arteriosus
Side effects: apnea in neonates

26
Q 
Epoprostenol
Therapeutic use:
Preparation:
MOA: 
Side effects:
A

PGI2

Therapeutic use: 1’ pulm HTN, rare disease in female
Preparation: continuous IV
MOA: IP:cAMP-mediated dilation pulmonary artery vascular smooth muscle
Side effects: nausea, vomiting, headache flushing

27
Q 
Bimatoprost 
Therapeutic use:
Preparation:
MOA: 
Side effects:
Therapeutic use:
Preparation:
MOA: 
Side effects:
A 
synthetic PGF2a
Therapeutic use:glaucoma
Preparation: ophthalmic 
MOA: increases outflow of aqueous humor, target receptor 
Side effects:redness itching eye color

Therapeutic use:
Preparation:
MOA:
Side effects:eyelash extention

PDA-2 (14 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions